Seasonal influenza vaccine development and mass production, as well as three international influenza vaccine cardiovascular outcomes trials currently underway, may inform future efforts targeted at developing and evaluating vaccine strategies for COVID-19, according to a new review.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/10/201005140819.htm
No comments:
Post a Comment